Senior insider sale
President and Chairman at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$790.5K
150K shares
What this filing means
GAD THOMAS plans to sell 150K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $790.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/20/2023ACC: 0001968582-23-000679
DirectorOfficer· President and Chairman
Since Sep 2018
150K
Shares to sell
$790.5K
Approx. market value
150K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Investment
Cash
8/15/2015
150KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2015 | Private Investment Cash | 150K | — |
| Total | 150K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
150K
Market value
$790.5K
11/20/2023
Total
Units
150K
Value
$790.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/20/2023 | 150K | $790.5K | Nasdaq | Planned |
| Total | 150K | $790.5K | ||